Harmony Biosciences Holdings, Inc.
HRMY- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001802665
In the last 90 days, Harmony Biosciences Holdings, Inc. insiders filed 0 open-market purchases and 2 sales; 328 institutions reported holding it in 13F filings for Q2 2026, worth $1.97B in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Harmony Biosciences Holdings, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 219
- +14 vs. Q1 2024
- Shares held
- 50.2M
- +1.22M (+2.5%) vs. Q1 2024
- Total value
- $1.51B
- −$130.0M (−7.9%) vs. Q1 2024
- New holders
- 35
- 75 more added
- Sold out
- 21
- 74 more reduced
2 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HRMY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 328 | $1.97B |
| Q1 2026 | 311 | $1.57B |
| Q4 2025 | 325 | $1.87B |
| Q3 2025 | 296 | $1.31B |
| Q2 2025 | 279 | $1.62B |
| Q1 2025 | 272 | $1.67B |
| Q4 2024 | 247 | $1.82B |
| Q3 2024 | 234 | $2.01B |
| Q2 2024 | 219 | $1.51B |
| Q1 2024 | 207 | $1.64B |
| Q4 2023 | 221 | $1.54B |
| Q3 2023 | 205 | $1.62B |
| Q2 2023 | 211 | $1.83B |
| Q1 2023 | 218 | $1.68B |
| Q4 2022 | 242 | $2.81B |
| Q3 2022 | 203 | $2.24B |
| Q2 2022 | 184 | $2.34B |
| Q1 2022 | 182 | $2.26B |
| Q4 2021 | 147 | $1.90B |
| Q3 2021 | 102 | $1.19B |
| Q2 2021 | 84 | $790.3M |
| Q1 2021 | 57 | $907.6M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Harmony Biosciences Holdings, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Charles Schwab Investment Management Inc | 374,708 | $11.3M | 0.00% | +1,192+0.3% | Added |
| Goldman Sachs Group Inc | 455,364 | $13.7M | 0.00% | +244,410+115.9% | Added |
| Massachusetts Financial Services Co | 519,701 | $15.7M | 0.00% | +13,547+2.7% | Added |
| Federated Hermes, Inc. | 525,524 | $15.9M | 0.04% | −170.0% | Reduced |
| LSV Asset Management | 578,246 | $17.4M | 0.04% | +243,100+72.5% | Added |
| Renaissance Technologies LLC | 595,800 | $18.0M | 0.03% | +215,700+56.7% | Added |
| American Century Companies Inc | 681,536 | $20.6M | 0.01% | +238,140+53.7% | Added |
| Citadel Advisors LLC | 684,318 | $20.6M | 0.02% | +102,698+17.7% | Added |
| Geode Capital Management, LLC | 748,703 | $22.6M | 0.00% | −5,074−0.7% | Reduced |
| Morgan Stanley | 836,111 | $25.2M | 0.00% | −49,234−5.6% | Reduced |
| Dimensional Fund Advisors LP | 956,785 | $28.9M | 0.01% | +112,197+13.3% | Added |
| venBio Partners LLC | 1,035,396 | $31.2M | 13.49% | 00.0% | Unchanged |
| State Street Corp | 1,273,498 | $38.4M | 0.00% | −22,046−1.7% | Reduced |
| Pacer Advisors, Inc. | 2,509,609 | $75.7M | 0.17% | +14,695+0.6% | Added |
| Vivo Capital, LLC | 2,606,247 | $78.6M | 7.26% | 00.0% | Unchanged |
| Vanguard Group Inc | 3,519,387 | $106.2M | 0.00% | −108,838−3.0% | Reduced |
| FMR LLC | 5,237,904 | $158.0M | 0.01% | −17,614−0.3% | Reduced |
| BlackRock Inc. | 5,835,243 | $176.0M | 0.00% | −87,518−1.5% | Reduced |
| Valor Management LLC | 11,218,033 | $338.4M | 74.43% | 00.0% | Unchanged |
| Paradiem, LLC | 0 | $0 | 0.00% | −93,930−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −63,269−100.0% | Sold out |
| Edgestream Partners, L.P. | 0 | $0 | 0.00% | −60,281−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −37,904−100.0% | Sold out |
| Texas Permanent School Fund | 0 | $0 | 0.00% | −28,706−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −17,408−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −14,809−100.0% | Sold out |
| New York Life Investment Management LLC | 0 | $0 | 0.00% | −11,136−100.0% | Sold out |
| Duality Advisers, LP | 0 | $0 | 0.00% | −9,864−100.0% | Sold out |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −8,420−100.0% | Sold out |
| ELCO Management Co., LLC | 0 | $0 | 0.00% | −6,955−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −6,247−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −3,508−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −1,735−100.0% | Sold out |
| FinTrust Capital Advisors, LLC | 0 | $0 | 0.00% | −34−100.0% | Sold out |
| Bell Investment Advisors, Inc | 0 | $0 | 0.00% | −32−100.0% | Sold out |
| Venturi Wealth Management, LLC | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Financial Synergies Wealth Advisors, Inc. | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Tfo-TDC, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Credit Suisse AG | – | – | – | – | Not filed |
| Cutler Group LP | – | – | – | – | Not filed |